author-photo

Yili Pritchett

Research Triangle Park

3

Papers

0

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies

2021 Cancer management and research
Show All
- Source
- Cite
- Save
Citations (0)
507TiP PRESERVE 1: A phase III, randomized, double-blind trial of trilaciclib versus placebo in patients receiving FOLFOXIRI/bevacizumab for metastatic colorectal cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)